Insider trades
Harlan S. Robins, Chief Officer of Adaptive Biotechnologies ADPT, has filed 0 purchases and 17 sales on the open market. Over the past 12 months that comes to a net sale of $10.4M. The latest trade was on 06/16.
Harlan S. Robins
Chief Scientific Officer
- First filing
- 23/03/08
- Trades
- 26 trades
- Buys / sales
- 0 / 17
- 12-month net buying
- −$10.4M
- Last trade
- 06/16
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ADPT | Open-market sale10b5-1 plan | 06/15–06/16 | 06/17 | 106,160 sh2 trades | $17.41avg. | $1,847,941.6 | −7.0% |
| Open-market sale10b5-1 plan | 04/08 | 04/10 | 10,000 sh | $14.85 | $148,500 | −0.7% | |
ADPT | Open-market sale | 03/11 | 03/13 | 470,266 sh2 trades | $13.17avg. | $6,193,403.22 | −23.6% |
ADPT | Open-market sale10b5-1 plan | 03/02–03/03 | 03/04 | 24,233 sh2 trades | $16.19avg. | $392,329.16 | −2.1% |
ADPT | Open-market sale10b5-1 plan | 02/02–02/03 | 02/04 | 42,788 sh2 trades | $18.68avg. | $799,104.8 | −3.5% |
| Open-market sale10b5-1 plan | 01/06 | 01/08 | 10,000 sh | $16.44 | $164,400 | −0.8% | |
ADPT | Open-market sale10b5-1 plan | 25/12/03–25/12/04 | 25/12/05 | 37,212 sh2 trades | $18.07avg. | $672,515.32 | −2.9% |
| Open-market sale10b5-1 plan | 25/11/10 | 25/11/12 | 10,000 sh | $14.82 | $148,200 | −0.8% | |
| Open-market sale10b5-1 plan | 25/05/01 | 25/05/05 | 68,412 sh | $7.35 | $502,828.2 | −5.1% | |
| Open-market sale10b5-1 plan | 25/03/24 | 25/03/26 | 1,698 sh | $9.00 | $15,282 | −0.1% | |
ADPT | Open-market sale | 25/03/05 | 25/03/06 | 96,656 sh2 trades | $6.99avg. | $675,219.41 | −7.0% |